摘要
目的探讨法舒地尔(fasudil)对脂多糖(LPS)诱导的急性肺损伤(ALI)大鼠的保护作用。方法45只雄性SD大鼠随机分为三组:对照组(NS组,n=15)、脂多糖组(LPS组,n=15)及法舒地尔干预组(FAS组,n=15),LPS组和FAS组采用股静脉注射LPS(5 mg/kg)建立ALI模型,FAS组在LPS注射前30 min腹膜内注射法舒地尔(10 mg/kg)。在3 h、6 h、12 h三个时间点通过血气分析、肺湿/干重比(W/D)、肺组织HE染色观察急性肺损伤的程度,酶联免疫吸附法(ELISA)检测血清中肿瘤坏死因子-a(TNF-a)和白介素-1β(IL-1β)水平。结果与LPS组相比,法舒地尔组在LPS注射后3 h、6 h和12 h时间点PaO2较LPS组显著升高(P<0.05),而肺组织W/D比值、肺损伤评分、血清TNF-α和IL-1β水平显著降低(P<0.05)。结论法舒地尔可以减轻脂多糖诱导的急性肺损伤大鼠的肺损伤程度,其机制可能与抑制致炎因子TNF-α和IL-1β的释放有关。
Objective To explore the potential protective effect of fasudil on acute lung injury (ALI) induced by lipopolysaccharide in rats. Methods A total of 45 male SD rats were randomly divided into three groups: control group ( NS group n = 15 ), lipopolysaccharide group ( LPS group n = 15 ) and fasudil treatment group ( FAS group n = 15). The all model was established by injecting LPS intravenously (5 mg/kg) in the LPS group and the FAS group. The FAS group was injected intraperitoneally with fasudil (10 mg/kg) thirty minutes before LPS injection. Tumor necrosis factor-α (TNF-α) and interleukin (IL) 1β (IL-1 beta) level in serum were measured through ELISA method, the blood gas analysis, lung tissue wet/dry weight ratio (W/D) ,lung tissue HE dyeing were tested in 3 h,6 h,12 h three time points after LIPS injection. Results In comparison with the LPS group,the arterial partial pressure of oxygen(PaO2) was significantly increased (P 〈 0. 05 ) and the ratio of lung tissue wet/dry weight (W/ D) ,Lung Injury Score and the levels of TNF-α and IL-1β in serum were significantly decreased( P 〈 0.05 ) in the FAS group in 3 h,6 h,12 h three time points after LPS injection. Conclusion Fasudil has a beneficial effect on the IS'S-induced acute lung injury of rats, which may be related to its effect in inhibiting the proimqammatory cytokines release of TNF-α and IL-1β.
出处
《中国临床保健杂志》
CAS
2012年第3期282-285,I0005,共5页
Chinese Journal of Clinical Healthcare
关键词
呼吸窘迫综合征
成人
脂多糖类
RHO相关激酶类
蛋白激酶抑制剂
模型
动物
Respiratory distress syndrome, adult
Lipopolysaccharides
rho-associated kinases
Protein kinaseinhibitors
Models, animal